In agreement, both miR-18a and miR-18b have been found to be upregulated in canine-mammary-cancer-derived cell lines [31], and in the sera of dogs with metastatic mammary carcinomas [32], and also, they have been predicted to target the ESR1 gene. This evidence concerns the gene ESR1 and breast cancer.